C.M. Bidwell & Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Hold
2,201
0.1% 135
2025
Q4
$217K Buy
2,201
+260
+13% +$25.2K 0.1% 128
2025
Q3
$165K Buy
+1,941
New +$153K 0.08% 148
2023
Q4
Sell
-1,695
Closed -$97.9K 531
2023
Q3
$97.9K Buy
+1,695
New +$107K 0.07% 235
2019
Q4
Sell
-4,700
Closed -$349K 425
2019
Q3
$349K Buy
+4,700
New +$380K 0.35% 84
2017
Q2
Sell
-16,695
Closed -$2.23M 352
2017
Q1
$2.23M Sell
16,695
-17,570
-51% -$2.24M 0.5% 81
2016
Q4
$3.44M Buy
+34,265
New +$3.34M 0.81% 67

Other funds holding INCY

C.M. Bidwell & Associates's INCY Position: Q1 2026 in Review

C.M. Bidwell & Associates held its Incyte (INCY) position steady in Q1 2026 at 2,201 shares worth $207K. The position accounts for 0.1% of the portfolio, ranked #135.

C.M. Bidwell & Associates first reported a position in INCY in Q4 2016 and has held it in 7 quarters since. The position peaked at $3.44M in Q4 2016. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • C.M. Bidwell & Associates held 2,201 shares of Incyte worth $207K as of Q1 2026.
  • C.M. Bidwell & Associates left its Incyte share count unchanged in Q1 2026.
  • Incyte made up 0.1% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #135 holding.
  • C.M. Bidwell & Associates first reported a position in Incyte in Q4 2016 and has held it in 7 quarters since.
  • C.M. Bidwell & Associates's Incyte position peaked at $3.44M in Q4 2016.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.